Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1993 1
1994 1
1996 1
1998 2
2001 1
2006 3
2007 1
2008 2
2009 1
2010 3
2011 2
2012 2
2013 5
2014 2
2016 1
2017 3
2018 4
2019 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
High expression of class III β-tubulin in upper gastrointestinal cancer types.
Höflmayer D, Öztürk E, Schroeder C, Hube-Magg C, Blessin NC, Simon R, Lang DS, Neubauer E, Göbel C, Heinrich MC, Fraune C, Möller K, Armbrust M, Freytag M, Hinsch A, Lühr C, Noack M, Reiswich V, Weidemann S, Bockhorn M, Perez D, Izbicki JR, Sauter G, Jacobsen F. Höflmayer D, et al. Among authors: lang ds. Oncol Lett. 2018 Dec;16(6):7139-7145. doi: 10.3892/ol.2018.9502. Epub 2018 Sep 25. Oncol Lett. 2018. PMID: 30546449 Free PMC article.
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy.
Schroeder C, Navid-Hill E, Meiners J, Hube-Magg C, Kluth M, Makrypidi-Fraune G, Simon R, Büscheck F, Luebke AM, Goebel C, Lang DS, Weidemann S, Neubauer E, Hinsch A, Jacobsen F, Lebok P, Michl U, Pehrke D, Huland H, Graefen M, Schlomm T, Sauter G, Höflmayer D. Schroeder C, et al. Among authors: lang ds. Oncotarget. 2019 Aug 13;10(48):4973-4986. doi: 10.18632/oncotarget.27132. eCollection 2019 Aug 13. Oncotarget. 2019. PMID: 31452838 Free PMC article.
The effect of dithiothreitol on the transcriptome of induced sputum cells.
Goldmann T, Pedersen F, Seehase S, Marwitz S, Lang DS, Kirsten AM, Zabel P, Vollmer E, Magnussen H, Rabe KF, Watz H. Goldmann T, et al. Among authors: lang ds. Respiration. 2013;86(3):262-3. doi: 10.1159/000348392. Epub 2013 Apr 9. Respiration. 2013. PMID: 23594515 Free article. No abstract available.
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer.
Büscheck F, Zub M, Heumann A, Hube-Magg C, Simon R, Lang DS, Höflmayer D, Neubauer E, Jacobsen F, Hinsch A, Luebke AM, Tsourlakis MC, Sauter G, Huland H, Graefen M, Haese A, Heinzer H, Schlomm T, Clauditz TS, Burandt E, Wilczak W, Steurer S, Minner S. Büscheck F, et al. Among authors: lang ds. Tumour Biol. 2019 Jul;41(7):1010428318824815. doi: 10.1177/1010428318824815. Tumour Biol. 2019. PMID: 31296150 Free article.
39 results